Proton Therapy contract finalized with Advocate Radiation Oncology Affiliate in Florida 

NEXT STORY
Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting
PREV STORY
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatric and Young Adult Patients at SIOP 2021 Virtual Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Allogene Therapeutics Adds Immunotherapy Luminaries, Thomas F. Gajewski, M.D., Ph.D., and Stephan Grupp, M.D., Ph.D., to its Scientific Advisory Board

author_avatar
NASDAQ Market News

FibroGen Receives Fast Track Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

author_avatar
NASDAQ Market News

At 9% CAGR, Global Targeted Therapy Market to Surpass US$ 180.3 Billion by 2028, Says Coherent Market Insights (CMI)

author_avatar
NASDAQ Market News